Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
    « Previous Issue | Next Issue »
  Cover Image

Volume 27, Issue 3; March 1, 2007

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

 

EditorialsBack

Osteopontin: A Bona Fide Mediator of Abdominal Aortic Aneurysm?

Mazen Shaheen and Neal L. Weintraub
Arterioscler Thromb Vasc Biol. 2007;27:439-441, doi:10.1161/01.ATV.0000258640.30287.7b.
Full Text | PDF  

Extracellular SOD Inactivation in High-Volume Hypertension: Role of Hydrogen Peroxide

Tohru Fukai
Arterioscler Thromb Vasc Biol. 2007;27:442-444, doi:10.1161/01.ATV.0000258920.36436.8e.
Full Text | PDF  

PLA2-V: A Real Player in Atherogenesis

Katariina Öörni and Petri T. Kovanen
Arterioscler Thromb Vasc Biol. 2007;27:445-447, doi:10.1161/01.ATV.0000258412.58289.ee.
Full Text | PDF  

RhoA-Dependent Vascular Smooth Muscle Cell–Specific Transcription: Adding Diaphanous Formins to the Puzzle

Erik Larsson, Xianghua Zhou, and Levent M. Akyürek
Arterioscler Thromb Vasc Biol. 2007;27:448-449, doi:10.1161/01.ATV.0000257573.32695.e1.
Full Text | PDF  

The Modern Art of Atherosclerosis: A Picture of Colorful Plants, Cholesterol, and Inflammation

Andrey Frolov and David Y. Hui
Arterioscler Thromb Vasc Biol. 2007;27:450-452, doi:10.1161/01.ATV.0000257134.75071.cb.
Full Text | PDF  

 

ATVB In FocusBack

Regulation of Hemostasis and Thrombosis: Insights from Murine Models

Daniel T. Eitzman
Arterioscler Thromb Vasc Biol. 2007;27:453, doi:10.1161/01.ATV.0000257138.15250.48.
Full Text | PDF  

Douglas M. Tollefsen
Arterioscler Thromb Vasc Biol. 2007;27:454-460; published online before print December 28 2006, doi:10.1161/01.ATV.0000256471.22437.88.
Abstract | Full Text | PDF  

Michael L. McCormick, Dan Gavrila, and Neal L. Weintraub
Arterioscler Thromb Vasc Biol. 2007;27:461-469; published online before print January 11 2007, doi:10.1161/01.ATV.0000257552.94483.14.
Abstract | Full Text | PDF  

 

Vascular BiologyBack

Oliver Jung, Stefan L. Marklund, Ning Xia, Rudi Busse, and Ralf P. Brandes
Arterioscler Thromb Vasc Biol. 2007;27:470-477; published online before print December 14 2006, doi:10.1161/01.ATV.0000254823.15843.1f.
Abstract | Full Text | PDF | Data Supplement
Effects of human extracellular superoxide dismutase (ecSOD) were determined in the 1-kidney-1-clip-model (1K1C). ecSOD lowered blood pressure and improved endothelial function in ecSOD+/+ and ecSOD-/- but not eNOS-/- mice. EcSOD expression increased in 1K1C but the protein was partially inactive from the reaction with peroxynitrite and hydrogen peroxide.  

Dean P. Staus, Alicia L. Blaker, Joan M. Taylor, and Christopher P. Mack
Arterioscler Thromb Vasc Biol. 2007;27:478-486; published online before print December 14 2006, doi:10.1161/01.ATV.0000255559.77687.c1.
Abstract | Full Text | PDF | Data Supplement
The RhoA effectors, mDia1 and mDia2, are strongly expressed in aortic SMCs and dramatically upregulate SMC-specific gene expression by stimulating the nuclear localization of the myocardin-related transcription factors. These results suggest that RhoA/mDia/MRTF signaling may serve to regulate SMC phenotype in response to extrinsic factors.  

Fredrik Lanner, Marcus Sohl, and Filip Farnebo
Arterioscler Thromb Vasc Biol. 2007;27:487-493; published online before print December 21 2006, doi:10.1161/01.ATV.0000255990.91805.6d.
Abstract | Full Text | PDF | Data Supplement
In this study we developed an ES cell in vitro differentiation system to address early specification of the developing vasculature into functional arteries and veins. We found arterial specification to be VEGF and Notch dependent, while inhibition of Notch signaling or low VEGF levels were permissive for venous differentiation.  

Anita K. Stannard, Rohit Khurana, Ian M. Evans, Vassiliki Sofra, David I.R. Holmes, and Ian Zachary
Arterioscler Thromb Vasc Biol. 2007;27:494-502; published online before print December 14 2006, doi:10.1161/01.ATV.0000255309.38699.6c.
Abstract | Full Text | PDF | Data Supplement
VEGF alone caused no significant induction of cell adhesion molecule expression in endothelial cells or during neointima formation in vivo. However, VEGF pretreatment enhanced E-selectin expression induced by TNF-{alpha}. These results indicate that VEGF "primes" endothelial cells to enhance selective responses to proinflammatory cytokines  

Yujuan Zheng, Makoto Watanabe, Takeshi Kuraishi, Shosaku Hattori, Chieko Kai, and Masabumi Shibuya
Arterioscler Thromb Vasc Biol. 2007;27:503-511; published online before print December 28 2006, doi:10.1161/01.ATV.0000256459.06671.3c.
Abstract | Full Text | PDF | Data Supplement
We report here that chimeric VEGF-ENZ7/PlGF molecules of low antigenicity accelerate skin wound healing with enhanced angiogenesis, less macrophage infiltration and lymphangiogenesis in both wild-type and diabetic mouse model. These findings clearly indicate that chimeric VEGF-ENZ7/PlGF molecules are superior to VEGF-A, and might be the potential drugs in therapeutic angiogenesis.  

Yasunobu Nishiwaki, Masayuki Yoshida, Hideki Iwaguro, Haruchika Masuda, Noriko Nitta, Takayuki Asahara, and Mitsuaki Isobe
Arterioscler Thromb Vasc Biol. 2007;27:512-518; published online before print December 14 2006, doi:10.1161/01.ATV.0000254812.23238.2b.
Abstract | Full Text | PDF
Although potential participation of bone marrow-derived circulating endothelial progenitor cells (EPCs) to neoangiogenesis has been proposed, the precise molecular mechanisms of EPC recruitment to vascular endothelium has not been fully elucidated.  

Min Xia, Wenhua Ling, Huilian Zhu, Qing Wang, Jing Ma, Mengjun Hou, Zhihong Tang, Lan Li, and Qinyuan Ye
Arterioscler Thromb Vasc Biol. 2007;27:519-524; published online before print December 7 2006, doi:10.1161/01.ATV.0000254672.04573.2d.
Abstract | Full Text | PDF | Data Supplement
Intracellular tumor necrosis factor receptor-associated factors (TRAFs) translocation to lipid rafts is a key element in CD40-induced signaling. The purpose of this study was to investigate the influence of anthocyanin on CD40-mediated proinflammatory events in human endothelial cells and the underlying possible molecular mechanism.  

Wassim Hodroj, Liliana Legedz, Nabil Foudi, Catherine Cerutti, Marie-Claude Bourdillon, Patrick Feugier, Michel Beylot, Jacques Randon, and Giampiero Bricca
Arterioscler Thromb Vasc Biol. 2007;27:525-531; published online before print December 14 2006, doi:10.1161/01.ATV.0000254814.63768.3b.
Abstract | Full Text | PDF
The involvement of local angiotensin system in atherosclerosis of type 2 diabetes was investigated in carotid endarterectomy specimens and derived VSMCs. We have shown basal overexpression of angiotensinogen and angiotensin type-1 receptor in carotid wall as well as an exaggerated insulin-induced stimulation of this expression in VSMCs from these patients.  

Reinier A. Boon, Joost O. Fledderus, Oscar L. Volger, Eva J.A. van Wanrooij, Evangelia Pardali, Frank Weesie, Johan Kuiper, Hans Pannekoek, Peter ten Dijke, and Anton J.G. Horrevoets
Arterioscler Thromb Vasc Biol. 2007;27:532-539; published online before print December 28 2006, doi:10.1161/01.ATV.0000256466.65450.ce.
Abstract | Full Text | PDF | Data Supplement
TGF-ß signaling in endothelium is generally considered proatherogenic. The shear stress-induced transcription factor KLF2 inhibits endothelial TGF-ß signaling by inducing the inhibitory Smad7 and suppressing the cofactor AP-1. This mechanism may contribute to the KLF2-mediated atheroprotection of shear stress.  

Chao-Hung Wang, Subodh Verma, I-Chang Hsieh, Agnes Hung, Ting-Tzu Cheng, Shin-Yi Wang, Yu-Chih Liu, William L. Stanford, Richard D. Weisel, Ren-Ke Li, and Wen-Jin Cherng
Arterioscler Thromb Vasc Biol. 2007;27:540-547; published online before print January 4 2007, doi:10.1161/01.ATV.0000257148.01384.7d.
Abstract | Full Text | PDF | Data Supplement
Apoptotic stimulation of VSMCs upregulated c-kit mRNA transcription and c-kit protein expression, which attracted SCF-positive cells, thus contributing to neointimal formation. The SCF attenuated the apoptosis of VSMCs through the Akt-Bcl-2 pathway. This study demonstrated that the SCF/c-kit system protects VSMCs against apoptosis and maintained intimal hyperplasia after vascular injury.  

Tomonori Haraguchi, Kenji Okada, Yasuhiko Tabata, Yoshimasa Maniwa, Yoshitake Hayashi, and Yutaka Okita
Arterioscler Thromb Vasc Biol. 2007;27:548-555; published online before print December 14 2006, doi:10.1161/01.ATV.0000254811.11741.2b.
Abstract | Full Text | PDF | Data Supplement
SR-BI/apoE double knockout (dKO) mice exhibit occlusive atherosclerotic coronary heart disease (CHD) characterized by myocardial infarctions, cardiac dysfunction, and premature death. Analysis of SR-BI/apoE/hepatic lipase (HL) triple knockout mice demonstrated that HL-deficiency reduces atherosclerosis, improves cardiac structure/function, and extends lifespan in this CHD model.  

Eiichiro Yamamoto, Takuro Yamashita, Tomoko Tanaka, Keiichiro Kataoka, Yoshiko Tokutomi, Zhong-Fang Lai, Yi-Fei Dong, Shinji Matsuba, Hisao Ogawa, and Shokei Kim-Mitsuyama
Arterioscler Thromb Vasc Biol. 2007;27:556-563; published online before print December 14 2006, doi:10.1161/01.ATV.0000254855.24394.f9.
Abstract | Full Text | PDF | Data Supplement
Olmesartan, pravastatin, and their combination were compared on vascular effects in salt-sensitive hypertensive rats (SS rats). Olmesartan or pravastatin improved vascular injury of SS rats, via different pleiotropic effects. Pravastatin enhanced vascular effect of olmesartan, via Akt and eNOS. ARB combined with statin is useful for treatment of salt-sensitive hypertension.  

Kyung Eun Kim, Chung-Hyun Cho, Hak-Zoo Kim, Peter Baluk, Donald M. McDonald, and Gou Young Koh
Arterioscler Thromb Vasc Biol. 2007;27:564-570; published online before print December 28 2006, doi:10.1161/01.ATV.0000256458.82320.be.
Abstract | Full Text | PDF | Data Supplement
Angiopoietins 1, 2, 3, and 4 elicited different amounts of blood and lymphatic vascular remodeling in normal and wound healing tissues. COMP-Ang1 and Ang2 given together produced an amount of vascular remodeling in normal vessels intermediate between the individual angiopoietins but had additive effects on vascular remodeling in skin wounds.  

Anita C. Thomas, Graciela B. Sala-Newby, Yasmin Ismail, Jason L. Johnson, Gerard Pasterkamp, and Andrew C. Newby
Arterioscler Thromb Vasc Biol. 2007;27:571-577; published online before print December 28 2006, doi:10.1161/01.ATV.0000256470.23842.94.
Abstract | Full Text | PDF | Data Supplement
Suppression subtraction hybridization showed upregulation of 3 and downregulation of 11 genes in rabbit foam cells compared with nonfoamy macrophages. FCMs had more MMP-12 but less arginase-I activity, leading to more NO production, which probably influences atherosclerosis.  

 

Atherosclerosis and LipoproteinsBack

Riikka Vikstedt, Dan Ye, Jari Metso, Reeni B. Hildebrand, Theo J.C. Van Berkel, Christian Ehnholm, Matti Jauhiainen, and Miranda Van Eck
Arterioscler Thromb Vasc Biol. 2007;27:578-586; published online before print December 14 2006, doi:10.1161/01.ATV.0000254815.49414.be.
Abstract | Full Text | PDF | Data Supplement
Systemic phospholipid transfer protein (PLTP) deficiency in mice is associated with a decreased susceptibility to atherosclerosis, whereas overexpression of human PLTP in mice increases atherosclerotic lesion development. PLTP is also expressed by macrophage-derived foam cells in human atherosclerotic lesions, but the exact role of macrophage PLTP in atherosclerosis is unknown. To clarify the role of macrophage PLTP in atherogenesis, PLTP was selectively disrupted in hematopoietic cells, including macrophages, by transplantation of bone marrow from PLTP knockout (PLTP-/-) mice into irradiated low-density lipoprotein receptor knockout mice. Macrophage PLTP is a significant contributor to plasma PLTP activity and deficiency of PLTP in macrophages leads to lowered atherosclerotic lesion development in low-density lipoprotein receptor knockout mice on Western-type diet.  

Guillermo Zalba, Ana Fortuño, Josune Orbe, Gorka San José, María U. Moreno, Miriam Belzunce, José Antonio Rodríguez, Oscar Beloqui, José Antonio Páramo, and Javier Díez
Arterioscler Thromb Vasc Biol. 2007;27:587-593; published online before print December 28 2006, doi:10.1161/01.ATV.0000256467.25384.c6.
Abstract | Full Text | PDF | Data Supplement
Enhanced {middle dot}O2- production increased MMP-9 activation in monocytes. NADPH oxidase and MMP-9 colocalized in atherosclerotic plaques. Enhanced NADPH oxidase-dependent {middle dot}O2- production associated with enhanced plasma MMP-9 levels in asymptomatic individuals. Interestingly, subjects in the upper quartile of {middle dot}O2- production associated with subclinical carotid atherosclerosis.  

Ruud Out, Menno Hoekstra, Illiana Meurs, Paula de Vos, Johan Kuiper, Miranda Van Eck, and Theo J.C. Van Berkel
Arterioscler Thromb Vasc Biol. 2007;27:594-599; published online before print January 4 2007, doi:10.1161/01.ATV.0000257136.24308.0c.
Abstract | Full Text | PDF
It has been shown that absence of macrophage ABCG1 may differentially influence atherosclerotic lesions dependent on the experimental setting and/or stage of atherosclerotic lesion development. In the current study we show that total body ABCG1 expression protects against early atherosclerotic lesion development.  

Meredith A. Bostrom, Boris B. Boyanovsky, Craig T. Jordan, Marilyn P. Wadsworth, Douglas J. Taatjes, Frederick C. de Beer, and Nancy R. Webb
Arterioscler Thromb Vasc Biol. 2007;27:600-606; published online before print January 4 2007, doi:10.1161/01.ATV.0000257133.60884.44.
Abstract | Full Text | PDF | Data Supplement
GV sPLA2 has been implicated in atherosclerosis in vitro. We demonstrate in mice that overexpression of GV sPLA2 in bone marrow cells results in increased atherosclerosis, whereas deficiency results in a reduction of atherosclerosis. We provide the first in vivo evidence that GV sPLA2 promotes atherosclerosis.  

Petra Keul, Markus Tölle, Susann Lucke, Karin von Wnuck Lipinski, Gerd Heusch, Mirjam Schuchardt, Markus van der Giet, and Bodo Levkau
Arterioscler Thromb Vasc Biol. 2007;27:607-613; published online before print December 7 2006, doi:10.1161/01.ATV.0000254679.42583.88.
Abstract | Full Text | PDF | Data Supplement
The S1P analogue FTY720 potently induces immunosuppression and activates eNOS. Therefore, we tested its effect on atherosclerosis in ApoE-/- mice. FTY720 dramatically reduced lesion volume, macrophage and collagen content and potently inhibited thrombin-induced release of MCP-1 via S1P3. Thus FTY720 may suppress the machinery regulating monocyte/macrophage emigration to atherosclerotic lesions.  

Jan K. Damås, Camilla Smith, Erik Øie, Børre Fevang, Bente Halvorsen, Torgun Wæhre, Agnes Boullier, Unni Breland, Arne Yndestad, Olga Ovchinnikova, Anna-Karin L. Robertson, Wiggo J. Sandberg, John Kjekshus, Kjetil Taskén, Stig S. Frøland, Lars Gullestad, Göran K. Hansson, Oswald Quehenberger, and Pål Aukrust
Arterioscler Thromb Vasc Biol. 2007;27:614-620; published online before print December 14 2006, doi:10.1161/01.ATV.0000255581.38523.7c.
Abstract | Full Text | PDF | Data Supplement
We show increased plasma levels of the homeostatic chemokines in CCL19 and CCL21 in clinical and experimental atherosclerosis. By promoting inflammatory responses in T-cells and by inducing a matrix degrading, prothrombotic, and inflammatory phenotype in macrophages, we suggest that these chemokines could contribute to atherogenesis and plaque destabilization.  

Zory Shaposhnik, Xuping Wang, Michael Weinstein, Brian J. Bennett, and Aldons J. Lusis
Arterioscler Thromb Vasc Biol. 2007;27:621-627; published online before print December 7 2006, doi:10.1161/01.ATV.0000254673.55431.e6.
Abstract | Full Text | PDF | Data Supplement
Recent evidence suggests that dendritic cells may play an important role in atherosclerosis. We hypothesized that granulocyte macrophage colony-stimulating factor (GM-CSF)-deficient mice would have decreased dendritic cells in lesions. Our data suggest that GM-CSF regulates dendritic cell formation in lesions and that this influences plaque growth and stability.  

Endre Dyrøy, Therese H. Røst, Reidar J. Pettersen, Bente Halvorsen, Oddrun A. Gudbrandsen, Thor Ueland, Ziad Muna, Fredrik Müller, Jan E. Nordrehaug, Pål Aukrust, and Rolf K. Berge
Arterioscler Thromb Vasc Biol. 2007;27:628-634; published online before print December 21 2006, doi:10.1161/01.ATV.0000255950.70774.d5.
Abstract | Full Text | PDF | Data Supplement
We explored the antioxidant, antiinflammatory, and hypolipidemic effects of TSA, a selenium-substituted fatty acid. Through mechanisms that seem to involve PPAR activation, TSA protects LDL from oxidation, has antiinflammatory effects in human leukocyte, and has lipid lowering properties in rat liver and plasma.  

Aki Hiuge, Alexander Tenenbaum, Norikazu Maeda, Michal Benderly, Masahiro Kumada, Enrique Z. Fisman, David Tanne, Zipora Matas, Toshiyuki Hibuse, Koichi Fujita, Hitoshi Nishizawa, Yehuda Adler, Michael Motro, Shinji Kihara, Iichiro Shimomura, Solomon Behar, and Tohru Funahashi
Arterioscler Thromb Vasc Biol. 2007;27:635-641; published online before print December 28 2006, doi:10.1161/01.ATV.0000256469.06782.d5.
Abstract | Full Text | PDF
Subanalysis of BIP study showed that bezafibrate significantly increased serum adiponectin and higher baseline adiponectin levels were associated with reduced risk of new diabetes. A series of experiments by using PPAR{alpha}-deficient mice and cells indicated that fibrates enhance adiponectin partly through adipose PPAR{alpha}.  

David Messika-Zeitoun, Lawrence F. Bielak, Patricia A. Peyser, Patrick F. Sheedy, Stephen T. Turner, Vuyisile T. Nkomo, Jerome F. Breen, Joseph Maalouf, Christopher Scott, A. Jamil Tajik, and Maurice Enriquez-Sarano
Arterioscler Thromb Vasc Biol. 2007;27:642-648; published online before print December 21 2006, doi:10.1161/01.ATV.0000255952.47980.c2.
Abstract | Full Text | PDF
Aortic valve calcification (AVC) in 262 population-based participants >=60 years was frequent (27%) with aging, with diabetes, and with coronary calcification. After 3.8{+/-}0.9 years, AVC score and prevalence increased. New AVC acquisition occurs with high LDL-cholesterol and progressive atherosclerosis. Larger established AVC determines faster AVC progression independently of atherosclerotic risk factors.  

T. Hansen, J. Wikström, L.O. Johansson, L. Lind, and H. Ahlström
Arterioscler Thromb Vasc Biol. 2007;27:649-654; published online before print December 14 2006, doi:10.1161/01.ATV.0000255310.47940.3b.
Abstract | Full Text | PDF | Data Supplement
Whole-body MRA, a minimally invasive, nonradiation technique, was used in a large cohort of elderly citizens and could be used in an epidemiological setting for quantifying atherosclerosis in different vascular territories, excluding the coronary arteries, in a single examination.  

Jonathan Golledge, Juanita Muller, Neil Shephard, Paula Clancy, Linda Smallwood, Corey Moran, Anthony E. Dear, Lyle J. Palmer, and Paul E. Norman
Arterioscler Thromb Vasc Biol. 2007;27:655-660; published online before print December 14 2006, doi:10.1161/01.ATV.0000255560.49503.4e.
Abstract | Full Text | PDF | Data Supplement
In this study the association of osteopontin (OPN) with human AAA was investigated. Serum OPN concentrations were related to AAA presence and growth; however, 5 polymorphisms in the OPN gene were not associated with AAA. Serum OPN may be a useful biomarker for AAA.  

Marianne Benn, Børge G. Nordestgaard, Gorm Boje Jensen, and Anne Tybjærg-Hansen
Arterioscler Thromb Vasc Biol. 2007;27:661-670; published online before print December 14 2006, doi:10.1161/01.ATV.0000255580.73689.8e.
Abstract | Full Text | PDF | Data Supplement
Apolipoprotein B (apoB) levels predict fatal myocardial infarction in men. Whether apoB also predicts nonfatal ischemic cardiovascular events is unclear. In the present study we show that apoB level is a predictor of an increased risk of: ischemic heart disease and myocardial infarction not only in men but also in women; ischemic cerebrovascular disease and ischemic stroke in women; and any ischemic cardiovascular event in both genders.  

Walter Osika, Frida Dangardt, Julia Grönros, Ulf Lundstam, Anna Myredal, Mats Johansson, Reinhard Volkmann, Tomas Gustavsson, Li Ming Gan, and Peter Friberg
Arterioscler Thromb Vasc Biol. 2007;27:671-676; published online before print December 28 2006, doi:10.1161/01.ATV.0000256468.95403.6f.
Abstract | Full Text | PDF
Using very high-resolution UBM (55 MHz), IT in peripheral arteries of both healthy subjects and patients was examined. Age was related to both MT and IT. Correlations were found between carotid IMT and IT/IMT. This new technique may aid in detecting early vascular abnormalities.  

Tommaso Fasano, Angelo B. Cefalù, Enza Di Leo, Davide Noto, Daniela Pollaccia, Letizia Bocchi, Vincenza Valenti, Renato Bonardi, Ornella Guardamagna, Maurizio Averna, and Patrizia Tarugi
Arterioscler Thromb Vasc Biol. 2007;27:677-681; published online before print December 14 2006, doi:10.1161/01.ATV.0000255311.26383.2f.
Abstract | Full Text | PDF | Data Supplement
Nonsense mutations in PCSK9 gene resulting in truncated PCSK9 protein were reported to be associated with reduced plasma LDL-C in blacks. Here we report a novel mutation producing a short truncated PCSK9 (Ala68fsLeu82X) in a kindred with familial hypobetalipoproteinemia and in a group of hypocholesterolemic white subjects.  

 

ThrombosisBack

Nicole Bassler, Christoph Loeffler, Pierre Mangin, Yuping Yuan, Meike Schwarz, Christoph E. Hagemeyer, Steffen U. Eisenhardt, Ingo Ahrens, Christoph Bode, Shaun P. Jackson, and Karlheinz Peter
Arterioscler Thromb Vasc Biol. 2007;27:E9-E15; published online before print December 14 2006, doi:10.1161/01.ATV.0000255307.65939.59.
Abstract | Full Text | PDF | Data Supplement
Limitations with intravenous and failure of oral {alpha}IIbß3 antagonists question the current concept of ligand-mimetic {alpha}IIbß3 blockade. We provide a model explaining paradoxical platelet activation as consequence of {alpha}IIbß3 antagonist-induced conformational change of {alpha}IIbß3. Concomitant blockade of the ADP-receptor P2Y12, activation-specific and allosteric blockade are described/discussed as alternative {alpha}IIbß3-blocking strategies.  

Geoffrey A. Allen, Egon Persson, Robert A. Campbell, Mirella Ezban, Ulla Hedner, and Alisa S. Wolberg
Arterioscler Thromb Vasc Biol. 2007;27:683-689; published online before print January 4 2007, doi:10.1161/01.ATV.0000257204.82396.2b.
Abstract | Full Text | PDF
We compared the effects of recombinant factor VIIa (rFVIIa) and analog NN1731 on procoagulant activity in hemophilia. This analog did not activate platelets, but exhibited higher platelet factor Xa and thrombin generation, and shortened the clotting time and increased fibrin formation and stability more than rFVIIa.  

Dennis J. Dietzen, Keith L. Page, Tina A. Tetzloff, Alan Bohrer, and John Turk
Arterioscler Thromb Vasc Biol. 2007;27:690-696; published online before print December 21 2006, doi:10.1161/01.ATV.0000255949.51053.ce.
Abstract | Full Text | PDF | Data Supplement
HMG-CoA reductase inhibitors may alter coagulation via effects on phospholipid metabolism. Atorvastatin treatment of EA.hy926 cells in combination with lipid restriction reduced cell cholesterol, phosphatidylserine, sphingomyelin, and ceramide but did not alter tissue factor expression. The resulting reduction in membrane exposure of phosphatidylserine blunted factor VIIa/tissue factor and prothrombinase activities.  

 

Letters to the EditorBack

Letter to the Editor: Decreased Atherosclerosis in Mice Deficient in Tumor Necrosis Factor-{alpha} Receptor-II (p75)

Unni M. Chandrasekharan, Lori Mavrakis, Jonathan D. Smith, Paul E. DiCorleto, and Tracy L. Bonfield
Arterioscler Thromb Vasc Biol. 2007;27:E16-E17, doi:10.1161/01.ATV.0000255551.33365.22.
Full Text | PDF  

Letter to the Editor: Autoreactive CD4+CD28 T Cells and Acute Coronary Syndromes

Behnam Zal, Christina Baboonian, and Juan Carlos Kaski
Arterioscler Thromb Vasc Biol. 2007;27:E18, doi:10.1161/01.ATV.0000254856.95617.38.
Full Text | PDF  

Letter to the Editor: Autoreactive CD4+CD28 T Cells and Acute Coronary Syndromes

Anna-Karin L. Robertson and Göran K. Hansson
Arterioscler Thromb Vasc Biol. 2007;27:E19, doi:10.1161/01.ATV.0000254821.40192.35.
Full Text | PDF  

Spotlight

TOC Spotlight File Banner1TOCpage

Banner2TOCpage